Jeff Dykan - Sep 13, 2023 Form 4 Insider Report for ReWalk Robotics Ltd. (RWLK)

Role
Director
Signature
/s/ Jeff Dykan
Stock symbol
RWLK
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
4
Date filed
9/19/2023, 05:37 PM
Previous filing
Aug 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RWLK Ordinary Shares, par value NIS 0.25 per share Award $0 +59.6K +100.06% $0.00 119K Sep 13, 2023 ESOP F1
holding RWLK Ordinary Shares, par value NIS 0.25 per share 65.7K Sep 13, 2023 By Partnership F2
holding RWLK Ordinary Shares, par value NIS 0.25 per share 50K Sep 13, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
F2 Consists of 50,488 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 65,655 shares of ReWalk Robotics Ltd.